IONS

IONS

USD

Ionis Pharmaceuticals Inc. Common Stock

$73.550-0.240 (-0.325%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$73.790

最高价

$75.000

最低价

$72.360

成交量

0.79M

公司基本面

市值

11.9B

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

2.47M

交易所

NMS

货币

USD

52周价格范围

最低价 $23.95当前价 $73.550最高价 $76.78

相关新闻

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $100 to $110.

查看更多
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110
Analyst Upgrades

Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77

Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $70 to $77.

查看更多
Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77
Analyst Upgrades

TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99

TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals with a Buy and raises the price target from $59 to $99.

查看更多
TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99
Analyst Upgrades

Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $90 to $94.

查看更多
Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $95 to $100.

查看更多
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100
Analyst Upgrades

Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $95

Barclays analyst Gena Wang maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $80 to $95.

Analyst Upgrades

RBC Capital Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $82

RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals with a Outperform and raises the price target from $80 to $82.